TGF-β1和PLGF在不同类型妊娠滋养细胞疾病患者病变组织中的表达及其意义

doi:10.13481/j.1671-587x.20180528

Abstract

Abstract: Objective:To detect the expressions of transforming growth factor-β1 (TGF-β1) and placental growth factor (PLGF) expressions in the tissue of the patients with different types of gestational trophoblastic diseases,and to clarfy the significances of their expressions in different types of gestational trophoblastic diseases. Methods:A total of 40 cases of hydatidiform mole tissue (hydatidiform mole group) and 26 cases of gestational trophoblastic tumour tissue (GTN group, including 22 cases of invasive hydatidiform mole and 4 cases of choriocarcinoma), and 40 cases of normal early pregnancy villi (normal control group) were collected.Immunohistochemical method was used to detect the positive expression rates of TGF-β1 and PLGF, the differences of TGF-β1 and PLGF expressions between normal group, hydatidiform mole group and GTN group were analyzed, and the associations between them and the clinical high risk factors(age>40 years old, the uterine volume> gestational age, and thecalutein ovarian cyst diameter>6 cm) were analyzed. Results:The positive expression rates of TGF-β1 in hydatidiform mole group(62.5%)and GTN group(30.8%) were lower than that in normal group(87.5%) (P<0.05);the positive expression rates of TGF-β1 in hydatidiform mole group was higher than that in GTN group(P<0.05).The positive expression rates of PLGF in hydatidiform mole group(50.5%) and GTN group(80.8%%) were higher than that in normal control group(22.5%%);the positive expression rate of PLGF in hydatidiform mole group was lower than that in GTN group (P<0.05).The positive expression rates of TGF-β1 of the patients in hydatidiform mole group with the age>40 years old, the uterine volume>the gestational age,and the ovarian luteinized cyst diameter>6 cm were significantly decreased (P<0.05) and the positive expression rates of PLGF were significantly increased (P<0.05) compared with normal control group.The positive expression rate of TGF-β1 of the patients in GTN group with the high risk factors was significantly decreased compared with those without the high risk factors(P<0.05) and the positive expression rate of PLGF was significantly increased (P<0.05).In hydatidiform mole group and GTN group, there were moderately negative correlations between the positive expression rates of TGF-β1 and PLGF (r=-0.585,P<0.05;r=-0.479, P<0.05). Conclusion:The expression levels of TGF-β1 in hydatidiform mole and gestational trophoblastic tumor are gradually decreased, and the expression levels of PLGF are gradually increased, which may be related to the different types and prognosis of gestational trophoblastic diseases.

Key words: gestational trophoblastic disease, transforming growth factor-β1, placental growth factor, immunohistochemistry

CLC Number:

R737.33

LI Hongxia, GONG Haiye, ZENG Xiao, ZHANG Susu, LIU Bofeng. Expressions of TGF-β1 and PLGF in tissue of patients with different types of gestational trophoblastic diseases and their significances[J].Journal of Jilin University(Medicine Edition), 2018, 44(05): 1041-1046.

References

[1] 向阳, 赵峻.妊娠滋养细胞疾病诊治进展[J]. 中国实用妇科与产科杂志, 2017, 33(1):14-18.
[2] Braga A, Maesta L, Short D, et al. Hormonal contraceptive ust before hcg remission does not increase the risk of gestational trophoblastic neoplasia following complete hydatidiform mole:a historical database review[J]. BJOG, 2016,123(8):1330-1335.
[3] Lu B, Zhang X, Liang Y. Clinicopathologic analysis of postchemotherapy gestational trophoblastic neoplasia:an entity overlapping with epithelioid trophoblastic tumor[J]. Int J Gynecol Pathol,2016,35(6):516-524.
[4] Brooks SA, Martin E, Smeester L, et al. miRNAs as common regulators of the transforming growth factor (TGF)-β pathway in the preeclamptic placenta and cadmium-treated trophoblasts:Links between the environment, the epigenome and preeclampsia[J]. Food Chem Toxicol, 2016, 98(Pt A):50-57.
[5] Bolat F, Haberal N, Tunali N, et al. Expression of vascular endothelial growth factor (VEGF), hypoxia inducible factor 1 alpha (HIF-1a), and transforming growth factors β1(TGFβ1) and β3(TGFβ3) in gestational trophoblastic disease[J]. Pathol Res Prac, 2010, 206(1):19-23.
[6] Singh MK, Bhattacharya D, Chaudhuri S, et al. T11TS inhibits glioma angiogenesis by modulation of MMPs, TIMPs, with related integrin αv and TGF-β1 expressions[J]. Tumour Biol, 2014, 35(3):2231-2246.
[7] 刘绍晨, 许倩, 岳志领.TGF-β1对人绒癌JEG-3细胞株TβRⅠ、TβRⅡ、Smad4 mRNA表达的影响及意义[J]. 中国妇幼保健, 2015, 30(5):758-763.
[8] Fu G, Ye G, Nadeem L, et al. MicroRNA-376c impairs transforming growth factor-β and nodal signaling to promote trophoblast cell proliferation and invasion[J]. Hypertension, 2013, 61(4):864-872.
[9] Singh MK, Bhattacharya D, Chaudhuri S, et al. T11TS inhibits glioma angiogenesis by modulation of MMPs, TIMPs, with related integrin αv and TGF-β1 expressions[J]. Tumour Biol, 2014, 35(3):2231-2246.
[10] Wu Y, Fu Y, Zheng L, et al. Nutlin-3 inhibits epithelial-mesenchymal transition by interfering with canonical transforming growth factor-β1-Smad-Snail/Slug axis[J]. Cancer Lett, 2014, 342(1):82-91.
[11] Wu XD, Chen LL,Shen T, et al. Curative effects and influenced factors of primary chemotherapy with single-agent methotrexate on low-risk gestational trophoblastic neoplasia[J].Zhonghua Yi Xue Za Zhi, 2017, 97(23):1769-1772.
[12] Schneider K, Weyerbrock A, Doostkam S, et al. Lack of evidence for PLGF mediating the tumor resistance after anti-angiogenic therapy in malignant gliomas[J]. J Neuro Oncol, 2015, 121(2):269-278.
[13] Vuorela P, Hatva E, Lymboussaki A, et al. Expression of vascular endothelial growth factor and placenta growth factor in human placenta[J].Biol Reprod,1997,56(2):489-494.
[14] Xiang L,Varshney R,Rashdan NA, et al. Placental growth factor and vascular endothelial growth factor-A have differential, cell-type specific patterns of expression in vascular cells[J]. Microcirculation,2014, 21(5):368-379.
[15] Tsiakkas A, Duvdevani N, Wright A, et al. Serum placental growth factor in the three trimesters of pregnancy:effects of maternal characteristics and medical history[J]. Ultrasound Obstet Gynecol, 2015, 45(5):591-598.
[16] Song N, Liu H, Ma X, et al. Placental growth factor promotes metastases of ovarian cancer through MiR-543-regulated MMP7[J]. Cell Physiol Biochem, 2015, 37(3):1104-1112.
[17] 李润花, 郑兆祥, 武明霞, 等. 胎盘生长因子及瘦素在早孕绒毛及妊娠滋养细胞疾病中的表达及意义[J]. 中华妇幼临床医学杂志:电子版, 2012, 8(4):485-488.
[18] Oranratanaphan S, Wongwathanavikrom R, Lertkhachonsuk R. Correlation levels of serum placental growth factor and human chorionic gonadotropin in gestational trophoblastic disease patients[J]. J Reprod Med, 2011, 56(7/8):333-338.
[19] De Falco S. The discovery of placenta growth factor and its biological activity[J]. Exp Mol Med, 2012, 44(1):1-9.
[20] Singh M, Kindelberger D, Nagymanyoki Z, et al. Vascular endothelial growth factors and their receptors and regulators in gestational trophoblastic diseases and normal placenta[J]. J Reprod Med, 2012, 57(5/6):197-203.
[21] Incio J, Tam J, Rahbari NN, et al. PLGF/VEGFR-1 signaling promotes macrophage polarization and accelerated tumor progression in obesity[J]. Clin Cancer Res, 2016, 22(12):2993-3004.
[22] Shamshiri Milani H, Abdollahi M, Torbati S, et al. Risk factors for hydatidiform mole:Is husband's job a major risk factor[J].Asian Pac J Cancer Prev,2017, 18(10):2657-2662.
[23] Giorgione V, Bergamini A, Cioffi R, et al.Role of surgery in the management of hydatidiform mole in elderly patients:a single-center clinical experience[J]. Int J Gynecol Cancer,2017,27(3):550-553.

Expressions of TGF-β1 and PLGF in tissue of patients with different types of gestational trophoblastic diseases and their significances

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Metrics

Comments

Recommended 0

[1]	ZHAO Zhenli, CHANG Jiwu, SUN Guang, HU Shaohua. Expression of AAX14401 in human bladder cancer tissue and its significance [J]. Journal of Jilin University(Medicine Edition), 2018, 44(05): 1052-1055.
[2]	WANG Tianyue, CUI Xiaoyan, WU Xiao, WANG Dan. Expression of phosphorylated extracellular signal-regulated kinase during development of hippocampus in mice [J]. Journal of Jilin University(Medicine Edition), 2018, 44(05): 979-982.
[3]	ZHANG Xiaohuan, DUAN Minghua, YAN Yuli, PAN Xin, LI Haiqing, ZHOU Changlong, ZHAO Tanyi. Isolation and identification of human amnion fibroblasts [J]. Journal of Jilin University Medicine Edition, 2018, 44(04): 845-848.
[4]	YAN Hui, LOU Shilei, MIAO Yongdi, QI Rui, GUO Zishuo, SUN Cong. Isolation,culture and identification of primary fibroblasts from rat colon [J]. Journal of Jilin University Medicine Edition, 2018, 44(04): 849-852.
[5]	BAO Xingfu, NI Yuxin, LI Ying, GUO Xiaokai, WANG Yuzhuo, FANG Jiao, HU Min. Expression characteristics of Wnt5a in different periods of cementum development and its effect on differentiationof cementoblasts of mice [J]. Journal of Jilin University Medicine Edition, 2018, 44(03): 461-465.
[6]	CAO Yansha, LI Hua, CHEN Minghong, LIU Baoqin, WANG Huaqin, LI Ning. Expression of BAG3 protein in colon cancer tissue detected by tissue microarray method and its clinical significance [J]. Journal of Jilin University Medicine Edition, 2017, 43(06): 1177-1181.
[7]	GAO Xinya, ZHANG Weijie, CUI Li, ZHOU Xueliang, MA Zhijun, LYU Zhuan, CHI Yanyan, WANG Liuxing. Expression of TM4SF1 in breast cancer tissue and its clinical significance [J]. Journal of Jilin University Medicine Edition, 2017, 43(06): 1186-1192.
[8]	ZHOU Shiping, XU Hong, WANG Xiu, LI Ying. Endoscopic submucosal dissection in treatment of esophageal granular cell tumor:A report of 2 cases and literature review [J]. Journal of Jilin University Medicine Edition, 2017, 43(05): 1034-1036.
[9]	LI Chun, FU Tianyue, YANG Baoxue, GAI Xiaodong. Expression of urea transporter B in human bladder cancer tissue and its clinical significance [J]. Journal of Jilin University Medicine Edition, 2017, 43(04): 705-708.
[10]	SHI Junzhong, ZHUANG Jianbin, ZHANG Chuanshan, LIU Xianming, KONG Dalu. Expression of β-tubulin Ⅲ in colon adenocarcinoma tissue and its clinical significance [J]. Journal of Jilin University Medicine Edition, 2017, 43(04): 770-775.
[11]	GUO Xiaokai, BAO Xingfu, YANG Junxing, WANG Yuzhuo, LI Yutong, HU Min. Morphological characteristics of expressions of DKK1 in different periods of tooth development in postnatal mice and their significances [J]. Journal of Jilin University Medicine Edition, 2017, 43(02): 241-244.
[12]	WEN Aiping, WANG Haijiao, JIN Jingji, CAI Yong, ZHU Jihong, CHEN Lunhua. Expressions of hMOFprotein and mRNA in endometrial cancer tissue and their clinical significances [J]. Journal of Jilin University Medicine Edition, 2016, 42(06): 1138-1142.
[13]	WEN Quan, WANG Yuanyuan, SI Henan, TIAN Yaping. Adult Langerhans cell histiocytosis: A case report and literature review [J]. Journal of Jilin University Medicine Edition, 2016, 42(05): 985-987.
[14]	GUO Li, YU Meiling, HAN Xiao, ZHANG Xiaoxia. Ovarian nonspecific steroid cell tumor: A case report and literature review [J]. Journal of Jilin University Medicine Edition, 2016, 42(05): 988-990.
[15]	KONG Guimei, WANG Jijun, TAO Wenhua, BU Ping, QIAN Feng. Expression of PRMT5 in human gastric cancer tissue and its significance [J]. Journal of Jilin University Medicine Edition, 2016, 42(04): 753-756.